Mycenax Biotech Cash Flow Quality Index
Mycenax Biotech cash flow quality index. Mycenax Biotech (4726) has a Cash Flow Quality Index of 3.23x as of March 2022. Operating cash flow of NT$59.07 Million exceeds net income of NT$18.31 Million, indicating high earnings quality where cash backs reported profits. See Mycenax Biotech financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Mycenax Biotech (2020–2020)
Cash flow quality index of Mycenax Biotech from 2020 to 2020. Historical Cash Flow Quality Index for Mycenax Biotech across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Mycenax Biotech to assess how comfortably operating cash covers total debt obligations.
Mycenax Biotech Cash Flow Quality Index by Year (2020–2020)
Mycenax Biotech cash flow quality index by year from 2020 to 2020. Year-by-year earnings quality comparison for Mycenax Biotech. For the full cash flow conversion analysis, see cash flow conversion of Mycenax Biotech.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 5.63x | NT$174.17 Million | NT$30.95 Million | — |